JMIR Aging achieves top ranking, accepted into prestigious science citation indexes
#1 ranked gerontology journal now included in Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) following exceptional performance
2024-12-11
(Press-News.org) (Toronto, December 11, 2024) JMIR Publications is proud to announce that JMIR Aging has been accepted for inclusion in the Science Citation Index Expanded (SCIE) and the Social Sciences Citation Index (SSCI).
This accomplishment follows a selective re-evaluation process, where a limited number of Emerging Sources Citation Index (ESCI) journals were considered for inclusion. To be eligible, journals needed to rank among the top three in their respective categories based on the latest Journal Citation Reports (JCR) data. JMIR Aging’s acceptance into SCIE and SSCI underscores its exceptional quality and impact, demonstrated by its outstanding performance across 24 quality and 4 impact measures. Notably, this milestone affirms the journal's excellence and leadership—with a Journal Impact Factor of 5.0, it was ranked #1 in the “Gerontology’ category in Clarivate’s 2024 Journal Citation Reports.
"The inclusion of JMIR Aging in SCIE underscores the growing recognition of the journal’s impact in the field of geriatrics and gerontology," say Dr Yun Jiang and Dr Jinjiao Wang, co-editors in chief of JMIR Aging. “With this significant achievement, we are more determined than ever to elevate the journal's reputation and contribute to the global conversation on using technology to address the challenges of caring for an aging population,” they further add.
We extend our gratitude to the editorial team, reviewers, and authors whose dedication has contributed to the journal's success.
###
About JMIR Publications
JMIR Publications, celebrating its 25th anniversary in 2024, is a leading open access digital health research publisher. As a pioneer in open access publishing, JMIR Publications is committed to driving innovation in scholarly communications, advancing digital health research, and promoting open science principles. Our portfolio features 36 open access, peer-reviewed journals dedicated to the dissemination of high-quality research in the field of digital health, including the Journal of Medical Internet Research, as well as cross-disciplinary journals such as JMIR Research Protocols and the new title JMIR XR & Spatial Computing.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media contact: communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-12-11
The majority of children who started smoking tobacco at age 10 years or in their later teens continued to smoke until their mid-twenties. Continuous smoking from childhood significantly increased the risk of premature heart damage, a new study shows. The study was conducted in collaboration between the Universities of Bristol and Exeter in the UK, and the University of Eastern Finland, and the results were published in the prestigious Journal of the American College of Cardiology (JACC).
In the present study, 1,931 children drawn from the University of Bristol’s Children of the 90s cohort were followed up from age 10 until 24 years. ...
2024-12-11
Cigarette smoking from childhood into early adulthood is associated with an increased risk of premature cardiac injury, according to a study published today in JACC, the flagship journal of the American College of Cardiology. This early damage to the structure and function of the heart can also significantly increase the chance of future cardiovascular (CVD) mortality in mid-life.
“Our goal is to provide data for policymakers, clinicians, and public health practitioners on crucial timing for preventing smoking and its early consequences in youth,” ...
2024-12-11
SAN ANTONIO —December 11, 2024 — Southwest Research Institute seeks support from residents or visitors of countries worldwide to assist with an international oil sampling program. Selected participants will be paid to purchase prequalified oil samples from retail stores and ship them to SwRI’s headquarters in San Antonio. Prequalification for the program will occur via an emailed photo exchange.
Participants will purchase four 1-quart or 1-liter containers, or one 1-gallon container, of specified brands ...
2024-12-11
Statistical and Engineering Approaches to Federated Learning: Comprehensive Benchmarking for Healthcare Applications
A groundbreaking study conducted by Duke-NUS Medical School evaluates federated learning (FL) methods to guide healthcare researchers in choosing privacy-preserving algorithms tailored to their clinical goals. This comprehensive benchmark compared statistical and engineering FL frameworks, offering actionable insights to balance predictive accuracy and interpretability in medical research.
Federated learning (FL) has emerged as a powerful tool in healthcare, enabling collaboration across institutions without compromising patient ...
2024-12-11
Drug addiction has been one of America’s growing public health concerns for decades. Despite the development of effective treatments and support resources, few people who are suffering from a substance use disorder seek help. Reluctance to seek help has been attributed to the stigma often attached to the condition. So, in an effort to address this problem, researchers at Drexel University are raising awareness of the stigmatizing language present in online forums and they have created an artificial intelligence tool to help educate users and offer alternative language.
Presented at the recent ...
2024-12-11
Religious believers are no more generous than atheists – at least as long as they don’t know what the recipient believes in. Finding this out increases generosity significantly, mainly because people give more to those who share their religion. This is the conclusion of a study carried out at Linköping University, Sweden.
Nathalie Hallin is an atheist. Her colleague Hajdi Moche is a Christian. They both have a postdoc position at the Department of Behavioural Sciences and Learning at Linköping. Together they wanted to find out if a religious belief makes a person more generous, which research has so far disagreed on and they themselves have ...
2024-12-11
SAN ANTONIO – Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median follow-up of 6.1 years, according to the latest results from the phase III OlympiA clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“The OlympiA trial examines adding one year of the oral PARP inhibitor olaparib after completion of standard treatment ...
2024-12-11
SAN ANTONIO – Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing salpingo-oophorectomy (RRSO) had lower rates of recurrence, secondary breast and/or ovarian malignancies, and death than those who did not undergo these surgeries, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“The benefits of RRM and RRSO have been shown for BRCA-mutation carriers without a prior history of cancer, but their impact for BRCA-mutation carriers with a history of early-onset breast cancer is less clear,” ...
2024-12-11
SAN ANTONIO – Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced breast cancer—as monotherapy in patients with ESR1 mutations and as combination therapy with abemaciclib (Verzenio) in all patients, regardless of ESR1 mutation status—according to results from the phase III EMBER-3 clinical trial presented at the San Antonio ...
2024-12-11
Carnegie Mellon University Africa and Challenger Center Collaborate to Deliver STEM Programs
Partnership Will Promote STEM Education and Careers to Secondary School Students in Africa
Carnegie Mellon University Africa, CMU’s College of Engineering location in Kigali, Rwanda, and Challenger Center, will partner to deliver Challenger Center’s Virtual Missions to hundreds of secondary school students on the continent. This project will help grow the population of African students who are motivated to pursue higher education and careers in science, technology, engineering, and math (STEM) fields.
Challenger Center’s Virtual Missions are space-themed experiences for students ...
LAST 30 PRESS RELEASES:
[Press-News.org] JMIR Aging achieves top ranking, accepted into prestigious science citation indexes
#1 ranked gerontology journal now included in Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI) following exceptional performance
